Clinical trial Recruiting at 1 site Interventional Ages 18 to 65 Women only

Spinal (intrathecal) morphine versus local bupivacaine for recovery after laparoscopic hysterectomy

Official title: Effects of Intrathecal Morphine Compared With Trocar-Site Infiltration and Intraperitoneal Bupivacaine on Postoperative Quality of Recovery and Inflammatory Markers After Laparoscopic Hysterectomy: A Prospective, Randomized, Double-Blind Controlled Trial

Run by Ataturk University · NCT07232108 · Data updated 2026-11-12

This will test whether a single spinal injection of morphine or local bupivacaine given at trocar sites and inside the abdomen better reduces pain and improves recovery for women having elective laparoscopic hysterectomy.

More Postoperative Pain Management trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexWomen only
Enrollment64 (estimated)
SponsorAtaturk University
Academic / other
Locations1 site (Erzurum)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedJune 1, 2026
Study endsJune 2, 2026
Registry record updatedDecember 8, 2025
Trial IDNCT07232108 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18–65 scheduled for elective laparoscopic hysterectomy for benign gynecologic conditions, ASA physical status I–III, who can give written informed consent are eligible.

Probably not a fit

Patients with contraindications to neuraxial or local anesthesia, chronic opioid dependence, severe renal or hepatic dysfunction, pregnancy, or breastfeeding are excluded and unlikely to benefit from the trial interventions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In a prospective, randomized, double-blind design, patients undergoing elective laparoscopic hysterectomy are assigned to receive either 200 µg intrathecal morphine before general anesthesia or trocar-site infiltration plus intraperitoneal bupivacaine during surgery, with all patients managed under a standardized anesthetic protocol. The primary patient-centered outcome is the Quality of Recovery (QoR-15) score, with additional measurement of postoperative pain scores, opioid consumption, opioid-related side effects, and hematologic inflammatory markers. Respiratory and hemodynamic monitoring is emphasized after intrathecal morphine, and follow-up assessments occur during the immediate postoperative period. The trial directly compares a central neuraxial analgesic technique with peripheral local-anesthetic approaches to identify which strategy best supports early recovery after minimally invasive hysterectomy.

Why it matters

Potential benefit: If successful, the preferred approach could provide better early pain relief, reduce opioid requirements, and speed recovery after laparoscopic hysterectomy.

How similar studies have gone: Previous randomized trials have shown that intrathecal morphine and intraperitoneal/trocar-site bupivacaine each reduce early postoperative pain and opioid use after minimally invasive gynecologic surgery, though direct head-to-head comparisons are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female patients aged 18-65 years.
* Elective laparoscopic hysterectomy planned for benign gynecological conditions.
* American Society of Anesthesiologists (ASA) physical status I-III.
* Ability to provide written informed consent.

Exclusion Criteria:

* Coagulopathy or bleeding disorders.
* Opioid dependence or chronic opioid use.
* Allergy or contraindication to local anesthetics or morphine.
* Contraindication to neuraxial (spinal) anesthesia.
* History of chronic pain syndromes.
* Severe renal or hepatic dysfunction.
* Pregnancy or breastfeeding.

Where it's running

  • Ataturk University
    Erzurum, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Ayşenur Dostbil, Principal Investigator — Ataturk University Department of Anesthesiology and Reanimation
  • Study coordinator: Ayşenur Dostbil, Associate Professor
  • Email: adostbil@hotmail.com
  • Phone: +90-533-367-66-96

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.